Voltage-gated sodium channels (VGSCs/Na v s), which control the flow of Na + and affect the generation of action potentials (APs), have been regarded as essential targets for many diseases. The biological and pharmacological functions of VGSCs have been extensively studied and many efforts have been made to discover and design ligands of VGSCs as potential therapies. Here, we summarize the recent and representative studies of VGSCs from the perspective of computer-aided drug design (CADD) and molecular modeling, including the structural biology of VGSCs, virtual screening and drug design toward VGSCs based on CADD, and functional studies using molecular modeling technologies. Furthermore, we conclude the achievements that have been made in the field of VGSCs and discuss the shortcomings found in previous studies. We hope that this review can provide some inspiration and reference for future investigations of VGSCs and drug design. This article is categorized under:Structure and Mechanism > Computational Biochemistry and Biophysicscomputer-aided drug design, molecular dynamic simulation, structural biology, voltage-gated sodium channels
| INTRODUCTIONVoltage-gated sodium channels (VGSCs/Na v s) are widely expressed in eukaryotes and prokaryotes, and play especially important roles in the generation and propagation of action potentials (APs). 1,2 Since Hodgkin and Huxley successfully recorded the first Na + -based APs from the giant axons of the squid Loligo, 3,4 researchers came to realize the important role of VGSCs in nerve impulse conduction, which opened a new door for VGSCs studies. To date, 10 subtypes of VGSCs (Na v 1.1-Na v 1.9 and Nax) have been found in mammals, and each subtype has its own unique functions (Table S1). Na v 1.1, Na v 1.2, Na v 1.3, and Na v 1.6 are primarily expressed in the central nervous system (CNS), and associated with many diseases such as epilepsy, migraine, autism, and ataxia. 5 Na v 1.4 is predominantly expressed in skeletal